Titlebook: Management of Early Stage Breast Cancer; Basics and Controver Beena Kunheri,D. K. Vijaykumar Book 2021 Springer Nature Singapore Pte Ltd. 2

慟哭

Surgical Management of Early Breast Cancer, carcinoma in situ and stage I, stage IIA, stage IIB and stage IIIA breast cancers. Early-stage breast cancers are potentially curable and always include surgical removal of breast tumour and axillary nodes. Surgery alone will result in long-term survival for a select group of patients, depending on cancer biology and the tumour stage.

galley

Ductal Carcinoma In Situ: Current Consensus in Management, 25–50% of patients with DCIS progress to invasive disease if untreated. The management of DCIS includes multiple treatment options including surgery, radiation therapy, and hormone therapy, thus making clinical decisions for the management of DCIS challenging. In this chapter, we discuss various treatment options for the management of DCIS.

會(huì)議

https://doi.org/10.1007/978-981-15-6171-9Early Breast Cancer; Sentinel Node; Breast Radiotherapy; Mammogram; Hypo fractionation in early breast c

LINES

高興去去

http://image.papertrans.cn/m/image/622487.jpg

TOM

978-981-15-6173-3Springer Nature Singapore Pte Ltd. 2021

善于騙人

Imaging: Controversies and Interventions in Early Breast Cancer,ing radiologists play a specialised role in deciding the optimum diagnostic investigation to be performed by following an age and symptom-based algorithm. A multidisciplinary team consisting of radiological imaging along with clinical assessment and pathological diagnosis forms the basis for the ass

開花期女

Molecular Mechanisms of Early Breast Cancer, and at an organismal level, heterogeneity can be due to different molecular profiles of the same tumor in different subjects (inter-patient) (Vogelstein et al., Science 339:1546–58, 2013). With the availability of high-resolution cellular imaging, next-generation sequencing, and rapid multiomic exp

貪婪性

Adjuvant Chemotherapy in Early Breast Cancer,although not incorporated into any guidelines. In a resource-starved setting like ours, we would continue to use clinico-pathological factors to base our decisions on adjuvant therapy in a large majority.

收集